Related Experiment Video
Updated: Feb 27, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Expanded Newborn Screening: Information and Resources for the Family Physician
1University of Nevada, Las Vegas School of Medicine, Las Vegas, NV, USA.
Insights
Newborn screening identifies over 30 core conditions annually. Family physicians must understand these tests, including expanded newborn screening, for effective parental communication and intervention, especially for metabolic disorders.
Area of Science:
- Medical Genetics
- Pediatrics
- Public Health
Background:
- State-mandated newborn screening impacts millions of infants annually.
- The Advisory Committee on Heritable Disorders in Newborns and Children recommends 34 core conditions for screening.
- Individual states manage, fund, and operate their own screening programs, leading to variations in practice.
Purpose of the Study:
- To inform family physicians about the scope and implications of newborn screening.
- To highlight the importance of understanding both core and expanded screening panels.
- To emphasize the need for early detection and intervention for metabolic disorders.
Main Methods:
- Review of current state-mandated newborn screening practices.
- Analysis of the core conditions included in newborn screening panels.
- Discussion of the role of family physicians in managing screening results and follow-up care.
Main Results:
- Newborn screening covers 34 core conditions, categorized into metabolic disorders, hemoglobinopathies, and other conditions like congenital hearing loss.
- Screening, diagnosis, and care coordination are managed at the state level, with significant variability in expanded testing.
- Family physicians play a crucial role in interpreting results and managing infants with positive findings.
Conclusions:
- Familiarity with expanded newborn screening tests is essential for family physicians.
- Physicians must recognize conditions not detected by standard screening or specific state panels.
- Long-term follow-up for diagnosed infants includes parental education, medical management, and developmental monitoring.
Abstract:
Each year, 4 to 5 million newborns receive state-mandated screening. Although the Advisory Committee on Heritable Disorders in Newborns and Children has identified 34 core conditions that should be incorporated into screening programs, each state manages, funds, and maintains its own program. State programs encompass screening, as well as the diagnosis and coordination of care for newborns with positive findings. Testing for core disorders is fairly standardized, but more extensive screening varies widely by state, and the rigorous evaluation of new screening panels is ongoing. The core panel includes testing for three main categories of disorders: metabolic disorders (e.g., amino acid and urea cycle, fatty acid oxidation, and organic acid disorders); hemoglobinopathies; and a group of assorted conditions, including congenital hearing loss. Family physicians must be familiar with the expanded newborn screening tests to effectively communicate results to parents and formulate interventions. They must also recognize signs of metabolic disorders that may not be detected by screening tests or that may not be a part of standard newborn screening in their state. For infants with positive screening results leading to diagnosis, long-term follow-up involves ongoing parental education, regular medical examinations, management at a metabolic treatment center, and developmental and neuropsychological testing to detect associated disorders in time for early intervention.
More Related Videos
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption